HOPE FM DELIVERS A FEEL-GOOD BUDGET

By Kiran Mazumdar-Shaw The Covid-19 pandemic has cast a gloomy outlook across the entire economy. Government coffers are depleting, Industry investments are shrinking, and citizens are being hit by inflation and job losses.  Budget 2022 is an event that everyone is hoping will deliver good news and I wish the Finance Minister will not dash our hopes! … Continue reading HOPE FM DELIVERS A FEEL-GOOD BUDGET

Budget Offers an Opportunity To Strengthen India’s R&D and Innovation Ecosystem

By Kiran Mazumdar-Shaw The Indian pharmaceutical industry has been playing a key role in improving global health through its affordable and high-quality generic medicines.  We are the third largest pharmaceuticals supplier in terms of volume, supplying 60,000 generic brands across 60 therapeutic categories worldwide. India now needs to capture value share as well. To move … Continue reading Budget Offers an Opportunity To Strengthen India’s R&D and Innovation Ecosystem

Technology holds huge promise for healthcare in India in 2022

By Kiran Mazumdar-Shaw The COVID-19 pandemic has caused a digital disruption in healthcare. It has accelerated innovation, catalysed technological breakthroughs, and created a fertile environment for the emergence of low-cost innovations anchored in affordability, and accessibility. It has also forced changes in consumer behaviour, persuaded doctors to become tech-savvy, prompted pharma companies to invest in … Continue reading Technology holds huge promise for healthcare in India in 2022

Kiran Mazumdar-Shaw’s Statement on John Shaw’s Offshore Trust

Notification to Stock Exchanges October 4, 2021 I would like to explain the situation relating to certain media reports on Pandora Papers which have referred to my husband John Shaw’s Offshore trust. I would like to state that these stories have grossly misrepresented the facts. I would therefore like to present the facts to you … Continue reading Kiran Mazumdar-Shaw’s Statement on John Shaw’s Offshore Trust

Healthcare for all must be built on the voices of all

The state of health care in India is far from optimal, a statement with which few of its 1.3 billion citizens would disagree. Even prior to the pandemic, reforming the health system was overdue, evidenced by poor health indicators, unequal delivery of quality care and inadequate protection from financial risk. Despite significant improvements in areas … Continue reading Healthcare for all must be built on the voices of all

$150-Billion Bioeconomy by 2025: Policy Prescriptions for Building a Vibrant Biotech Sector

By Kiran Mazumdar-Shaw In the face of the biggest health calamity faced by humanity in a century, India’s Bioeconomy grew over 12% to reach $70.2 billion in 2020. The biotech industry braved the challenges of Covid-19 to develop innovative solutions such as diagnostics, therapies and vaccines at speed and scale to save countless lives. India … Continue reading $150-Billion Bioeconomy by 2025: Policy Prescriptions for Building a Vibrant Biotech Sector

Prioritising Women’s & Girls’ Needs for Sexual and Reproductive Health and Family Planning Services during Covid-19 and beyond.

As part of Population Foundation of India's Conversation Series, Biocon Executive Chairperson Kiran Mazumdar-Shaw participated in a panel discussion on understanding the vulnerabilities of women and girls, and addressing issues related to sexual and reproductive health (SRH) and family planning (FP), which have been exacerbated due to the pandemic. In her remarks, she said India … Continue reading Prioritising Women’s & Girls’ Needs for Sexual and Reproductive Health and Family Planning Services during Covid-19 and beyond.

Fireside Chat: Kiran Mazumdar Shaw and Robert Bradway, Chairman & CEO of Amgen at USAIC’s 15th Annual BioPharma Summit

The USA-India Chamber of Commerce (USAIC) hosted a ‘Chairman To Chairman’ Fireside Chat between Biocon Executive Chairperson Kiran Mazumdar-Shaw and Amgen Chairman & CEO Bob Bradway during its 15th annual BioPharma Summit (Virtual). The one-on-one discussion covered a host of topics, including the biopharma industry’s response to COVID-19, accelerated adoption of digital technologies, and topics … Continue reading Fireside Chat: Kiran Mazumdar Shaw and Robert Bradway, Chairman & CEO of Amgen at USAIC’s 15th Annual BioPharma Summit

Science, Technology and Innovation: How DBT coordinated India’s COVID-19 fight

By Kiran Mazumdar-Shaw The COVID-19 pandemic has proven that science can rescue humanity. And for science to prosper you need to have dedicated national agencies that are relentlessly driving the agenda of science. Since its inception in 1982, The Department of Biotechnology (DBT) has made tremendous efforts in promoting bioscience research, translational education and entrepreneurship. … Continue reading Science, Technology and Innovation: How DBT coordinated India’s COVID-19 fight